THERE'S A LOT TO LOVE
ABOUT LO LOESTRIN FE
THERE'S ONLY ONE
LO LOESTRIN FE
Lo Loestrin Fe is the only available low-dose birth control pill with
10 mcg of daily estrogen.
Please see LO LOESTRIN FE Prescribing Information, including Boxed Warning, and Patient Information.
[TEXT ON SCREEN]
GET TO KNOW LO LOESTRIN® FE
WATCH TILL THE END FOR IMPORTANT SAFETY INFO
Lo Loestrin® Fe is a prescription birth control pill used for the prevention of pregnancy. If you are moderately obese, discuss with your healthcare provider whether Lo Loestrin Fe is appropriate for you.
VOICE OVER:
Let’s talk about pregnancy prevention with Lo Loestrin Fe.
Watch till the end for important safety info.
Lo Lo is a low-dose combination birth control pill.
And the #1-prescribed branded birth control pill by OB-GYNs.
VOICE OVER:
Combo pills contain two hormones—progestin and estrogen, which keep the ovaries from releasing an egg.
Without an egg, sperm have nothing to fertilize, which helps prevent pregnancy.
This is important to know—birth control pills can have serious risks and side effects and smoking increases risks, especially if you’re over 35.
[TEXT ON SCREEN]
THE BIRTH CONTROL PILL WITH THE LOWEST DAILY DOSE OF ESTROGEN AVAILABLE.
VOICE OVER:
Lo Lo is the only available low-dose combination birth control pill with 10 micrograms of daily estrogen.
[TEXT ON SCREEN]
KEEP WATCHING FOR IMPORTANT SAFETY INFO
VOICE OVER:
Lo Lo is also an extended regimen pill because it has only 2 placebo pills—the brown ones.
[TEXT ON SCREEN]
LO LOESTRIN® FE
PREGNANCY PREVENTION THAT MAY ALSO RESULT IN SHORT, LIGHTER PERIODS
VOICE OVER:
Lo Lo offers pregnancy prevention that may result in short, lighter periods, too.
How much estrogen does your birth control pill have?
Ask your doctor about getting in the Lo, with Lo Loestrin Fe.
[TEXT ON SCREEN]
FOR PREGNANCY PREVENTION
[LO LOESTRIN FE LOGO]
Lo Loestrin Fe is a prescription birth control pill used for the prevention of pregnancy. If you are moderately obese, discuss with your healthcare provider whether Lo Loestrin Fe is appropriate for you.
Do not use Lo Loestrin Fe if you smoke cigarettes and are over 35 years old. Smoking increases your risk of serious cardiovascular side effects (heart and blood vessel problems) from birth control pills, including death from heart attack, blood clots, or stroke. This risk increases with age and the number of cigarettes you smoke.
Do not use Lo Loestrin Fe if you have or have had blood clots, history of heart attack or stroke, high blood pressure that medicine cannot control, breast cancer, liver disease or liver tumors, unexplained bleeding from the vagina, or if you take Hepatitis C drugs containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, as this may increase levels of liver enzymes in the blood.
Treatment with Lo Loestrin Fe should be stopped if you have a blood clot, and at least 4 weeks before and through 2 weeks after major surgery. You should not take Lo Loestrin Fe any earlier than 4 weeks after having a baby, or if you are breastfeeding. If you experience yellowing of the skin or eyes due to problems with your liver, you should stop taking Lo Loestrin Fe. If you are prediabetic or diabetic, your doctor should monitor you while using Lo Loestrin Fe. Your doctor should evaluate you if you have any significant change in headaches or irregular menstrual bleeding. Lo Loestrin Fe should not be taken during pregnancy.
Lo Loestrin Fe increases the risk of serious conditions including blood clots, stroke, and heart attack. These can be life-threatening or lead to permanent disability.
The most common side effects reported by women taking Lo Loestrin Fe in a study were nausea/vomiting, headache, spotting or bleeding between menstrual periods, painful menstruation, weight change, breast tenderness, acne, abdominal pain, anxiety, and depression.
Birth control pills do not protect you against any sexually transmitted disease, including HIV, the virus that causes AIDS.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
Please see the full Prescribing Information, including Boxed Warning, and Patient Information.
LO LOESTRIN FE IS AN EXTENDED-REGIMEN BIRTH CONTROL PILL
It has 26 days of “active pills” (with hormones) and 2 days of “reminder pills” (without hormones).
WHAT'S IN
EACH PILL
1 milligram
norethindrone acetate
(progestin) and
10
micrograms ethinyl
estradiol (estrogen)
10 micrograms
ethinyl estradiol
(estrogen)
75 milligrams
ferrous fumarate
(iron)
WHEN TO
START LO LO
NEW TO HORMONAL BIRTH CONTROL?
Your healthcare provider may tell you
to start Lo Loestrin Fe on the first day of
your period. This is the day you start
bleeding or spotting (even if it is almost
midnight when the bleeding begins).
You should take a Lo Loestrin Fe pill
every day until the pack is empty. Then
you start a new pill pack.
TAKING LO LOESTRIN FE:
WHAT TO EXPECT AND WHEN
Your body will need time to adjust to Lo Loestrin Fe. Here’s a sneak peek at
what to
expect when starting–and staying–on Lo Loestrin Fe.
WEEKS
PLAY IT SAFE
Start Lo Loestrin Fe on the first day of your period. If you start on any other day, use a back-up method of birth control–like a condom and spermicide–for the first 7 days.
Pro tip: Lo Loestrin Fe does not protect against STDs, so make it a habit to use a condom every time you have sex.
LO LO
BLEEDING AND SPOTTING
It’s not uncommon to have some bleeding and spotting between periods. This is sometimes called
“breakthrough” bleeding and usually occurs during the first few months of use.
However, about one-third of women who use Lo Loestrin Fe had breakthrough bleeding that continued after one year of use.
If the breakthrough bleeding is heavy or lasts for more than a few days, you should discuss this with your healthcare provider.
you may see a change
in your periods
While taking Lo Loestrin Fe for pregnancy prevention,
most women had a period that lasted LESS THAN 2 DAYS per cycle, on average.
Some women experienced periods that were
LIGHTER THAN NORMAL.
MISS A PERIOD? IT HAPPENS
In a clinical study, about half of women missed a period after their first year (cycle 13) on Lo Loestrin Fe.
Call your healthcare provider if you go two or more months in a row without a period, or you miss your period after a month when you did not take all your pills correctly.
Notify your healthcare provider if you have symptoms of pregnancy, such as morning sickness or unusual breast tenderness. Stop taking
Lo Loestrin Fe if you are pregnant.
Lo Loestrin Fe is a prescription birth control pill used for the prevention of pregnancy. If you are moderately obese, discuss with your healthcare provider whether Lo Loestrin Fe is appropriate for you.
Do not use Lo Loestrin Fe if you smoke cigarettes and are over 35 years old. Smoking increases your risk of serious cardiovascular side effects (heart and blood vessel problems) from birth control pills, including death from heart attack, blood clots, or stroke. This risk increases with age and the number of cigarettes you smoke.
Do not use Lo Loestrin Fe if you have or have had blood clots, history of heart attack or stroke, high blood pressure that medicine cannot control, breast cancer, liver disease or liver tumors, unexplained bleeding from the vagina, or if you take Hepatitis C drugs containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, as this may increase levels of liver enzymes in the blood.
Treatment with Lo Loestrin Fe should be stopped if you have a blood clot, and at least 4 weeks before and through 2 weeks after major surgery. You should not take Lo Loestrin Fe any earlier than 4 weeks after having a baby, or if you are breastfeeding. If you experience yellowing of the skin or eyes due to problems with your liver, you should stop taking Lo Loestrin Fe. If you are prediabetic or diabetic, your doctor should monitor you while using Lo Loestrin Fe. Your doctor should evaluate you if you have any significant change in headaches or irregular menstrual bleeding. Lo Loestrin Fe should not be taken during pregnancy.
Lo Loestrin Fe increases the risk of serious conditions including blood clots, stroke, and heart attack. These can be life-threatening or lead to permanent disability.
The most common side effects reported by women taking Lo Loestrin Fe in a study were nausea/vomiting, headache, spotting or bleeding between menstrual periods, painful menstruation, weight change, breast tenderness, acne, abdominal pain, anxiety, and depression.
Birth control pills do not protect you against any sexually transmitted disease, including HIV, the virus that causes AIDS.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
Please see the full
Prescribing Information, including Boxed Warning, and Patient
Information.
Please see the full
Prescribing Information, including Boxed Warning, and
Patient
Information.
Lo Loestrin Fe is a prescription birth control pill used for the prevention of pregnancy. If you are moderately obese, discuss with your healthcare provider whether Lo Loestrin Fe is appropriate for you.
Do not use Lo Loestrin Fe if you smoke cigarettes and are over 35 years old. Smoking increases your risk of serious cardiovascular side effects (heart and blood vessel problems) from birth control pills, including death from heart attack, blood clots, or stroke. This risk increases with age and the number of cigarettes you smoke.
Do not use Lo Loestrin Fe if you have or have had blood clots, history of heart attack or stroke, high blood pressure that medicine cannot control, breast cancer, liver disease or liver tumors, unexplained bleeding from the vagina, or if you take Hepatitis C drugs containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, as this may increase levels of liver enzymes in the blood.
Treatment with Lo Loestrin Fe should be stopped if you have a blood clot, and at least 4 weeks before and through 2 weeks after major surgery. You should not take Lo Loestrin Fe any earlier than 4 weeks after having a baby, or if you are breastfeeding. If you experience yellowing of the skin or eyes due to problems with your liver, you should stop taking Lo Loestrin Fe. If you are prediabetic or diabetic, your doctor should monitor you while using Lo Loestrin Fe. Your doctor should evaluate you if you have any significant change in headaches or irregular menstrual bleeding. Lo Loestrin Fe should not be taken during pregnancy.
Lo Loestrin Fe increases the risk of serious conditions including blood clots, stroke, and heart attack. These can be life-threatening or lead to permanent disability.
The most common side effects reported by women taking Lo Loestrin Fe in a study were nausea/vomiting, headache, spotting or bleeding between menstrual periods, painful menstruation, weight change, breast tenderness, acne, abdominal pain, anxiety, and depression.
Birth control pills do not protect you against any sexually transmitted disease, including HIV, the virus that causes AIDS.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
Please see the full Prescribing Information, including Boxed Warning, and Patient Information.
Do not use Lo Loestrin Fe if you smoke cigarettes and are over 35 years old. Smoking increases your risk of serious cardiovascular side effects (heart and blood vessel problems) from birth control pills, including death from heart attack, blood clots, or stroke. This risk increases with age and the number of cigarettes you smoke.
Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) is a prescription birth control pill used for the prevention of pregnancy. If you are moderately obese, discuss with your healthcare provider whether Lo Loestrin Fe is appropriate for you.
Do not use Lo Loestrin Fe if you have or have had blood clots, history of heart attack or stroke, high blood pressure that medicine cannot control, breast cancer, liver disease or liver tumors, unexplained bleeding from the vagina, or if you take Hepatitis C drugs containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, as this may increase levels of liver enzymes in the blood.
Treatment with Lo Loestrin Fe should be stopped if you have a blood clot, and at least 4 weeks before and through 2 weeks after major surgery. You should not take Lo Loestrin Fe any earlier than 4 weeks after having a baby, or if you are breastfeeding. If you experience yellowing of the skin or eyes due to problems with your liver, you should stop taking Lo Loestrin Fe. If you are prediabetic or diabetic, your doctor should monitor you while using Lo Loestrin Fe. Your doctor should evaluate you if you have any significant change in headaches or irregular menstrual bleeding. o Loestrin Fe should not be taken during pregnancy.
Lo Loestrin Fe increases the risk of serious conditions including blood clots, stroke, and heart attack. These can be life-threatening or lead to permanent disability.
The most common side effects reported by women taking Lo Loestrin Fe in a study were nausea/vomiting, headache, spotting or bleeding between menstrual periods, painful menstruation, weight change, breast tenderness, acne, abdominal pain, anxiety, and depression.
Birth control pills do not protect you against any sexually transmitted disease, including HIV, the virus that causes AIDS.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
Please see the full
Prescribing Information, including Boxed Warning, and Patient
Information.
By clicking this link, you will be leaving this site and connecting to a site neither owned nor operated by AbbVie. AbbVie is not responsible for the contents of any such website or any further links from such website. AbbVie is providing these links as a convenience, and the inclusion of any link does not imply endorsement of the linked website by AbbVie. You should also be aware that the linked website may be governed by its own set of terms and conditions and privacy policy, for which AbbVie has no responsibility.
US-LOL-220430